| EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes JJM Van Dongen, L Lhermitte, S Böttcher, J Almeida, ... Leukemia 26 (9), 1908-1975, 2012 | 1042 | 2012 |
| EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols T Kalina, J Flores-Montero, VHJ Van Der Velden, M Martin-Ayuso, ... Leukemia 26 (9), 1986-2010, 2012 | 820 | 2012 |
| Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002 J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ... Journal of clinical oncology 32 (3), 174-184, 2014 | 400 | 2014 |
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 388 | 2017 |
| The genetic basis and cell of origin of mixed phenotype acute leukaemia TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ... Nature 562 (7727), 373-379, 2018 | 289 | 2018 |
| Antigen expression patterns reflecting genotype of acute leukemias O Hrušák, A Porwit-MacDonald Leukemia 16 (7), 1233-1258, 2002 | 254 | 2002 |
| Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial F Locatelli, G Zugmaier, C Rizzari, JD Morris, B Gruhn, T Klingebiel, ... Jama 325 (9), 843-854, 2021 | 221 | 2021 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 219 | 2020 |
| Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group C Langebrake, U Creutzig, M Dworzak, O Hrusak, E Mejstrikova, ... Journal of Clinical Oncology 24 (22), 3686-3692, 2006 | 170 | 2006 |
| Quality assessment program for E uro F low protocols: Summary results of four‐year (2010–2013) quality assurance rounds T Kalina, J Flores‐Montero, Q Lecrevisse, CE Pedreira, ... Cytometry Part A 87 (2), 145-156, 2015 | 158 | 2015 |
| Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by … J Trka, M Kalinova, O Hrušák, J Zuna, O Krejčí, J Madžo, P Sedláček, ... Leukemia 16 (7), 1381-1389, 2002 | 149 | 2002 |
| AIEOP‐BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia MN Dworzak, B Buldini, G Gaipa, R Ratei, O Hrusak, D Luria, E Rosenthal, ... Cytometry Part B: Clinical Cytometry 94 (1), 82-93, 2018 | 138 | 2018 |
| CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment E Mejstríková, O Hrusak, MJ Borowitz, JA Whitlock, B Brethon, TM Trippett, ... Blood cancer journal 7 (12), 659, 2017 | 131 | 2017 |
| Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study S Mukkada, N Bhakta, GL Chantada, Y Chen, Y Vedaraju, L Faughnan, ... The Lancet Oncology 22 (10), 1416-1426, 2021 | 119 | 2021 |
| Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? E Fronkova, E Mejstrikova, S Avigad, KW Chik, L Castillo, S Manor, ... Leukemia 22 (5), 989-997, 2008 | 101 | 2008 |
| Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort M Zaliova, J Stuchly, L Winkowska, A Musilova, K Fiser, M Slamova, ... Haematologica 104 (7), 1396, 2019 | 97 | 2019 |
| TEL/AML1 positivity in childhood ALL: average or better prognosis? J Zuna, O Hrušák, M Kalinova, K Mužíková, J Starý, J Trka Leukemia 13 (1), 22-24, 1999 | 97 | 1999 |
| ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia J Zuna, J Madzo, O Krejci, Z Zemanova, M Kalinova, K Muzikova, ... Blood, The Journal of the American Society of Hematology 117 (1), 368-369, 2011 | 92 | 2011 |
| Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria E Mejstrikova, J Volejnikova, E Fronkova, K Zdrahalova, T Kalina, ... Haematologica 95 (6), 928, 2010 | 88 | 2010 |
| International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia O Hrusak, V De Haas, J Stancikova, B Vakrmanova, I Janotova, ... Blood, The Journal of the American Society of Hematology 132 (3), 264-276, 2018 | 86 | 2018 |
